A request has been made for individuals to share their experiences if GLP-1 drugs, including Wegovy and Mounjaro, have not worked for them. This call aims to gather stories from people for whom these medications were ineffective.
It is reported that approximately 5-10% of those who use GLP-1 drugs fall into this category. The request seeks details on whether the drugs were unbearable or if no benefit was observed despite extended use, and if stigma was encountered.